These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17392433)

  • 1. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.
    Pestka JM; Zeisel MB; Bläser E; Schürmann P; Bartosch B; Cosset FL; Patel AH; Meisel H; Baumert J; Viazov S; Rispeter K; Blum HE; Roggendorf M; Baumert TF
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6025-30. PubMed ID: 17392433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
    Lavillette D; Morice Y; Germanidis G; Donot P; Soulier A; Pagkalos E; Sakellariou G; Intrator L; Bartosch B; Pawlotsky JM; Cosset FL
    J Virol; 2005 May; 79(10):6023-34. PubMed ID: 15857988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
    Kaplan DE; Sugimoto K; Newton K; Valiga ME; Ikeda F; Aytaman A; Nunes FA; Lucey MR; Vance BA; Vonderheide RH; Reddy KR; McKeating JA; Chang KM
    Gastroenterology; 2007 Feb; 132(2):654-66. PubMed ID: 17258733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
    Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatitis C virus glycan shield and evasion of the humoral immune response.
    Helle F; Duverlie G; Dubuisson J
    Viruses; 2011 Oct; 3(10):1909-32. PubMed ID: 22069522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
    Dowd KA; Netski DM; Wang XH; Cox AL; Ray SC
    Gastroenterology; 2009 Jun; 136(7):2377-86. PubMed ID: 19303013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
    von Hahn T; Yoon JC; Alter H; Rice CM; Rehermann B; Balfe P; McKeating JA
    Gastroenterology; 2007 Feb; 132(2):667-78. PubMed ID: 17258731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.
    Takaki A; Wiese M; Maertens G; Depla E; Seifert U; Liebetrau A; Miller JL; Manns MP; Rehermann B
    Nat Med; 2000 May; 6(5):578-82. PubMed ID: 10802716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
    PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response in acute hepatitis C virus infection.
    Netski DM; Mosbruger T; Depla E; Maertens G; Ray SC; Hamilton RG; Roundtree S; Thomas DL; McKeating J; Cox A
    Clin Infect Dis; 2005 Sep; 41(5):667-75. PubMed ID: 16080089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
    El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
    Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
    Ahsan A; Dar S; Hassan F; Ghafoor F; Yousuf MH; Shahzad-Ul-Hussan S
    PLoS One; 2021; 16(8):e0256816. PubMed ID: 34449828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
    Merat SJ; Bru C; van de Berg D; Molenkamp R; Tarr AW; Koekkoek S; Kootstra NA; Prins M; Ball JK; Bakker AQ; de Jong MD; Spits H; Beaumont T; Schinkel J
    J Hepatol; 2019 Jul; 71(1):14-24. PubMed ID: 30797052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.
    Meuleman P; Bukh J; Verhoye L; Farhoudi A; Vanwolleghem T; Wang RY; Desombere I; Alter H; Purcell RH; Leroux-Roels G
    Hepatology; 2011 Mar; 53(3):755-62. PubMed ID: 21319203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.
    Urbanowicz RA; McClure CP; Brown RJ; Tsoleridis T; Persson MA; Krey T; Irving WL; Ball JK; Tarr AW
    J Virol; 2015 Dec; 90(7):3288-301. PubMed ID: 26699643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).
    Bailey JR; Urbanowicz RA; Ball JK; Law M; Foung SKH
    Methods Mol Biol; 2019; 1911():441-450. PubMed ID: 30593644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.